lobbying_activities: 997141

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
997141	299a11b0-4a6e-4077-988d-7544ee873734	Q3	MEHLMAN CONSULTING, INC.	284950	ABBOTT LABORATORIES	2010	third_quarter	PHA	Drug pricing, FDA reforms, Reimbursement.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2010-10-18T11:46:46.107000-04:00